Yüklüyor......
Combinational therapy of crizotinib and afatinib for malignant pleural mesothelioma
Malignant pleural mesothelioma (MPM) is a relative rare but highly aggressive neoplasm which is associated with asbestos exposure in most patients. The majority of patients are diagnosed in advanced stages so patients neither benefit from chemotherapy (e.g. pemetrexed-platinum combination) nor from...
Kaydedildi:
| Yayımlandı: | Am J Cancer Res |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
e-Century Publishing Corporation
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5336496/ https://ncbi.nlm.nih.gov/pubmed/28337371 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|